U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07622017) titled 'KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer' on May 27.
Brief Summary: This phase II clinical trial is evaluating whether adding KRC-01 injections to standard chemoradiotherapy may improve treatment outcomes in patients with locally advanced rectal cancer without metastases.
KRC-01 is an investigational product designed to improve the effectiveness of radiotherapy by increasing oxygen levels inside tumors, which may help radiation work better. KRC-01 contains hydrogen peroxide and sodium hyaluronate and is injected directly into the tumor before radiotherapy sessions.
Previous clinical experience in Ja...